Facility ICV-3C at the Paris Brain Institute offers single-cell sequencing solutions that enable the study of gene expression and the epigenome at the single-cell level.
Thanks to next-generation sequencing (NGS) technologies, this approach enables the exploration of cellular diversity with high precision and a better understanding of the biological mechanisms specific to each cell.
Chromium iX (10x Genomics)

Facility ICV-3C is equipped with 10x Genomics’ Chromium iX system, enabling single-cell transcriptomic and epigenomic analysis.
In particular, this technology enables the study of cellular heterogeneity in tissues by identifying the different cell populations that make them up. It also offers the possibility of exploring states of cell differentiation and detecting rare cell populations.
Applications of Chromium iX
The Chromium iX system enables various approaches to single-cell sequencing, including the analysis of gene expression from whole cells (scRNA-seq) or isolated nuclei (snRNA-seq), as well as the study of chromatin accessibility (scATAC-seq).
For 3’ gene expression analysis, the technology relies on sequencing the 3’ end of RNA transcripts, enabling their expression to be characterised at the single-cell level.
Facility ICV-3C processes your suspension cell samples and carries out the various experimental steps: cell partitioning, cell barcoding, library preparation and sequencing.
The raw sequencing data is then made available to you for bioinformatic analysis.